6月3日，京东健康盘中下跌3.52%，报38.3港元/股，成交额8808.45万港元。同期互联网与直销零售板块整体走弱，美团跌4.33%、京东集团跌3.75%、阿里健康跌2.88%。
消息面上，国家药监局近期发布《处方药网络零售合规指南》正式落地，明确处方审核须由执业药师完成，禁止AI代为审方，同时禁止处方药在首页展示及以赠送、直播等方式促销。实测显示，京东等平台高热度GLP-1减重注射剂已无法在线直接购买，线上销售链路已作调整。新规全面抬升合规门槛，互联网处方药零售正从"流量转化"逻辑回归医疗安全逻辑，短期对平台药品收入形成压力。此外，公司自5月15日以来已连续回购累计4.74亿港元，但期间股价仍累计下跌逾18%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.